4.6 Article

sodC-Based Real-Time PCR for Detection of Neisseria meningitidis

Journal

PLOS ONE
Volume 6, Issue 5, Pages -

Publisher

PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pone.0019361

Keywords

-

Funding

  1. Brazilian National Council for Scientific and Technological Development (CNPq) [309196/2007-8]
  2. National Institute of Science and Technology for Health Technology Assessment/IATS
  3. National Institutes of Health [5D43TW006592]

Ask authors/readers for more resources

Real-time PCR (rt-PCR) is a widely used molecular method for detection of Neisseria meningitidis (Nm). Several rt-PCR assays for Nm target the capsule transport gene, ctrA. However, over 16% of meningococcal carriage isolates lack ctrA, rendering this target gene ineffective at identification of this sub-population of meningococcal isolates. The Cu-Zn superoxide dismutase gene, sodC, is found in Nm but not in other Neisseria species. To better identify Nm, regardless of capsule genotype or expression status, a sodC-based TaqMan rt-PCR assay was developed and validated. Standard curves revealed an average lower limit of detection of 73 genomes per reaction at cycle threshold (C-t) value of 35, with 100% average reaction efficiency and an average R-2 of 0.9925. 99.7% (624/626) of Nm isolates tested were sodC-positive, with a range of average C-t values from 13.0 to 29.5. The mean sodC C-t value of these Nm isolates was 17.6 +/- 2.2 (+/- SD). Of the 626 Nm tested, 178 were nongroupable (NG) ctrA-negative Nm isolates, and 98.9% (176/178) of these were detected by sodC rt-PCR. The assay was 100% specific, with all 244 non-Nm isolates testing negative. Of 157 clinical specimens tested, sodC detected 25/157 Nm or 4 additional specimens compared to ctrA and 24 more than culture. Among 582 carriage specimens, sodC detected Nm in 1 more than ctrA and in 4 more than culture. This sodC rt-PCR assay is a highly sensitive and specific method for detection of Nm, especially in carriage studies where many meningococcal isolates lack capsule genes.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Immunology

A Longitudinal, Observational Study of Etiology and Long-Term Outcomes of Sepsis in Malawi Revealing the Key Role of Disseminated Tuberculosis

Joseph M. Lewis, Madlitso Mphasa, Lucy Keyala, Rachel Banda, Emma L. Smith, Jackie Duggan, Tim Brooks, Matthew Catton, Jane Mallewa, Grace Katha, Stephen B. Gordon, Brian Faragher, Melita A. Gordon, Jamie Rylance, Nicholas A. Feasey

Summary: This study describes the causes and long-term outcomes of sepsis in Malawi, finding that disseminated tuberculosis is the dominant cause and receiving antituberculous chemotherapy is associated with improved survival. Late deaths in individuals living with HIV contribute significantly to post-discharge mortality. These findings suggest the need for locally adapted sepsis protocols in sub-Saharan Africa and highlight the importance of considering distinct pathogens and novel treatment strategies.

CLINICAL INFECTIOUS DISEASES (2022)

Article Immunology

Thirteen-Valent Pneumococcal Conjugate Vaccine-Induced Immunoglobulin G (IgG) Responses in Serum Associated With Serotype-Specific IgG in the Lung

Elena Mitsi, Daniella McLenaghan, Asia-Sophia Wolf, Scott Jones, Andrea M. Collins, Angela D. Hyder-Wright, David Goldblatt, Robert S. Heyderman, Stephen B. Gordon, Daniela M. Ferreira

Summary: This study found that immunization with 13-valent pneumococcal conjugate vaccine elicits serotype-specific immunoglobulin G (IgG) responses, with serum IgG levels to correlate with those measured in bronchoalveolar lavage samples, but shows poor immunogenicity against serotype 3 in both sites.

JOURNAL OF INFECTIOUS DISEASES (2022)

Article Multidisciplinary Sciences

Innovative vaccine approaches-a Keystone Symposia report

Jennifer Cable, Rino Rappuoli, Elizabeth J. Klemm, Gagandeep Kang, Ankur Mutreja, Gavin J. Wright, Mariagrazia Pizza, Sowmya Ajay Castro, Joseph P. Hoffmann, Galit Alter, Andrea Carfi, Andrew J. Pollard, Florian Krammer, Ravindra K. Gupta, Caroline E. Wagner, Viviane Machado, Kayvon Modjarrad, Lawrence Corey, Peter B. Gilbert, Gordon Dougan, Nicole Lurie, Pamela J. Bjorkman, Christopher Chiu, Elisa Nemes, Stephen B. Gordon, Andrew C. Steer, Thomas Rudel, Catherine A. Blish, John Tyler Sandberg, Kiva Brennan, Keith P. Klugman, Lynda M. Stuart, Shabir A. Madhi, Christopher L. Karp

Summary: The rapid development of COVID-19 vaccines is the result of years of research and collaboration, but access and efficacy issues still exist in low-and-middle-income countries. Addressing these issues requires innovative research, deeper understanding of vaccine protection, and innovative trial designs and models.

ANNALS OF THE NEW YORK ACADEMY OF SCIENCES (2022)

Article Immunology

Hepatitis B Vaccination Impact and the Unmet Need for Antiviral Treatment in Blantyre, Malawi

Alexander J. Stockdale, James E. Meiring, Isaac T. Shawa, Deus Thindwa, Niza M. Silungwe, Maurice Mbewe, Rabson Kachala, Benno Kreuels, Pratiksha Patel, Priyanka Patel, Marc Y. R. Henrion, Naor Bar-Zeev, Todd D. Swarthout, Robert S. Heyderman, Stephen B. Gordon, Anna Maria Geretti, Melita A. Gordon

Summary: A study conducted in Blantyre, Malawi found that infant HBV vaccination has been highly effective in reducing HBsAg prevalence in adults, but some HBsAg-positive adults have an unmet need for antiviral therapy.

JOURNAL OF INFECTIOUS DISEASES (2022)

Article Ethics

When the universal is particular: a re-examination of the common morality using the work of Charles Taylor

Michelle C. Bach

Summary: Beauchamp and Childress's biomedical principlism is synonymous with medical ethics for most clinicians, but its global authority should be questioned. The viability of the common morality is challenged, highlighting its cultural particularity.

MEDICINE HEALTH CARE AND PHILOSOPHY (2022)

Article Medicine, General & Internal

AstraZeneca COVID-19 vaccine induces robust broadly cross-reactive antibody responses in Malawian adults previously infected with SARS-CoV-2

Marah G. Chibwana, Thandeka Moyo-Gwete, Gaurav Kwatra, Jonathan Mandolo, Tandile Hermanaus, Thopisang Motlou, Nonkululeko Mzindle, Frances Ayres, Mphatso Chaponda, Godwin Tembo, Percy Mwenechanya, Ndaona Mitole, Chisomo Jassi, Raphael Kamng'ona, Louise Afran, David Mzinza, Henry C. Mwandumba, Stephen B. Gordon, Khuzwayo Jere, Shabir Madhi, Penny L. Moore, Robert S. Heyderman, Kondwani C. Jambo

Summary: This study aimed to assess the dynamics of anti-Spike antibodies in an African adult population with prior SARS-CoV-2 infection and determine the effect of subsequent COVID-19 vaccination. The findings showed that neutralizing antibodies wane within 6 months post-infection, but a single dose of the AstraZeneca COVID-19 vaccine significantly increased antibody levels. Furthermore, the antibodies generated after vaccination demonstrated broad cross-reactivity against multiple variants and had neutralizing potency.

BMC MEDICINE (2022)

Article Immunology

High Intrapulmonary Rifampicin and Isoniazid Concentrations Are Associated With Rapid Sputum Bacillary Clearance in Patients With Pulmonary Tuberculosis

Andrew D. McCallum, Henry E. Pertinez, Aaron P. Chirambo, Irene Sheha, Madalitso Chasweka, Rose Malamba, Doris Shani, Alex Chitani, Jane E. Mallewa, Jamilah Z. Meghji, Jehan F. Ghany, Elizabeth L. Corbett, Stephen B. Gordon, Geraint R. Davies, Saye H. Khoo, Derek J. Sloan, Henry C. Mwandumba

Summary: This study explores the relationship between intrapulmonary drug levels and sputum bacillary clearance in tuberculosis treatment. The results show that higher drug exposure to rifampicin or isoniazid in the epithelial lining fluid is associated with more rapid bacillary elimination. Higher doses of rifampicin and isoniazid may result in sustained high intrapulmonary drug exposure, rapid bacillary clearance, shorter treatment duration, and better treatment outcomes.

CLINICAL INFECTIOUS DISEASES (2022)

Article Public, Environmental & Occupational Health

A secondary data analysis of a cluster randomized controlled trial: improved cookstoves associated with reduction in incidence of low birthweight in rural Malawi

Rebecca Best, Jullita Mvala, Albert Dube, Cynthia Katundu, Fredrick Kalobekamo, Kevin Mortimer, Stephen B. Gordon, Moffat Nyirenda, Amelia Crampin, Estelle McLean

Summary: This study provides evidence that an improved cookstove intervention in rural Malawi may reduce the number of babies born with low birthweight. This finding is supported by additional subset analysis. The intervention appears to decrease the number of infants born prematurely or with intra-uterine growth restriction, indicating that improved cookstoves could be a beneficial maternal health intervention.

INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2022)

Article Critical Care Medicine

Human Infection Challenge with Serotype 3 Pneumococcus

Ryan E. Robinson, Elena Mitsi, Elissavet Nikolaou, Sherin Pojar, Tao Chen, Jesus Reine, Tinashe K. Nyazika, James Court, Kelly Davies, Madlen Farrar, Partricia Gonzalez-Dias, Josh Hamilton, Helen Hill, Lisa Hitchins, Ashleigh Howard, Angela Hyder-Wright, Maia Lesosky, Konstantinos Liatsikos, Agnes Matope, Daniella McLenaghan, Christopher Myerscough, Annabel Murphy, Carla Solorzano, Duolao Wang, Hassan Burhan, Manish Gautam, Elizabeth Begier, Christian Theilacker, Rohini Beavon, Annaliesa S. Anderson, Bradford D. Gessner, Stephen B. Gordon, Andrea M. Collins, Daniela M. Ferreira

Summary: This study evaluated the colonization ability and safety of Streptococcus pneumoniae serotype 3 (SPN3) in the nasopharynx using a human challenge model. The results showed that colonization rates varied with inoculum doses and isolate types, and colonization may cause mild upper respiratory symptoms.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2022)

Article Immunology

Changing Incidence of Invasive Pneumococcal Disease in Infants Less Than 90 Days of Age Before and After Introduction of the 13-Valent Pneumococcal Conjugate Vaccine in Blantyre, Malawi: A 14-Year Hospital Based Surveillance Study

Marianne Koenraads, Todd D. Swarthout, Naor Bar-Zeev, Comfort Brown, Jacquline Msefula, Brigitte Denis, Queen Dube, Stephen B. Gordon, Robert S. Heyderman, Melissa J. Gladstone, Neil French

Summary: This study examined the burden of invasive pneumococcal disease (IPD) in infants <90 days old in Blantyre, Malawi over a 14-year period and evaluated the impact of the pneumococcal conjugate vaccine (PCV13) on vaccine-serotype IPD in this population. The results showed that vaccine serotypes 1 and 5 were the main cause of IPD in neonates and young infants, both before and after PCV13 introduction.

PEDIATRIC INFECTIOUS DISEASE JOURNAL (2022)

Article Medicine, General & Internal

Protocol for a phase IV double-blind randomised controlled trial to investigate the effect of the 13-valent pneumococcal conjugate vaccine and the 23-valent pneumococcal polysaccharide vaccine on pneumococcal colonisation using the experimental human pneumococcal challenge model in healthy adults (PREVENTING PNEUMO 2)

Konstantinos Liatsikos, Angela Hyder-Wright, Sherin Pojar, Tao Chen, Duolao Wang, Kelly Davies, Christopher Myerscough, Jesus Reine, Ryan E. Robinson, Britta Urban, Elena Mitsi, Carla Solorzano, Stephen B. Gordon, Angela Quinn, Kaijie Pan, Annaliesa S. Anderson, Christian Theilacker, Elizabeth Begier, Bradford D. Gessner, Andrea Collins, Daniela M. Ferreira

Summary: This article summarizes a study protocol for investigating the effect of the 13-valent pneumococcal conjugate vaccine (PCV13) and the 23-valent pneumococcal polysaccharide vaccine (PPV23) on pneumococcal nasopharyngeal colonization. The study will use experimental human pneumococcal challenge to assess acquisition, density, and duration of colonization, as well as immune responses and antigenuria. The primary outcome is to compare the acquisition rate of pneumococcal serotype 3 (SPN3) between vaccinated and unvaccinated groups.

BMJ OPEN (2022)

Article Immunology

Quality of antibody responses by adults and young children to 13-valent pneumococcal conjugate vaccination and Streptococcus pneumoniae colonisation

Asia -Sophia Wolf, Elena Mitsi, Scott Jones, Simon P. Jochems, Lucy Roalfe, Deus Thindwa, James E. Meiring, Jacquline Msefula, Farouck Bonomali, Tikhala Makhaza Jere, Maurice Mbewe, Andrea M. Collins, Stephen B. Gordon, Melita A. Gordon, Daniela M. Ferreira, Neil French, David Goldblatt, Robert S. Heyderman, Todd D. Swarthout

Summary: This study investigates the protective mechanism of childhood pneumococcal conjugate vaccine (PCV) against pneumococcal carriage. The results show no clear relationship between antibody quality and protection from carriage, suggesting that PCV13-driven antibody quality may mature with age and exposure.

VACCINE (2022)

Article Infectious Diseases

Effect of resistance to third-generation cephalosporins on morbidity and mortality from bloodstream infections in Blantyre, Malawi: a prospective cohort study

Rebecca Lester, Patrick Musicha, Kondwani Kawaza, Josephine Langton, James Mango, Helen Mangochi, Winnie Bakali, Oliver Pearse, Jane Mallewa, Brigitte Denis, Sithembile Bilima, Stephen B. Gordon, David G. Lalloo, Christopher P. Jewell, Nicholas A. Feasey

Summary: The study found that resistance to third-generation cephalosporins is associated with increased mortality and longer hospital stays in patients with bloodstream infections in Malawi. It highlights the urgent need for resource allocation towards antimicrobial resistance mitigation strategies in Africa.

LANCET MICROBE (2022)

Correction Medicine, Research & Experimental

Innate and adaptive nasal mucosal immune responses following experimental human pneumococcal colonization (vol 129, pg 4523, 2019)

Simon P. Jochems, Karin de Ruiter, Carla Solorzano, Astrid Voskamp, Elena Mitsi, Elissavet Nikolaou, Beatriz F. Carniel, Sherin Pojar, Esther L. German, Jesus Reine, Alessandra Soares-Schanoski, Helen Hill, Rachel Robinson, Angela D. Hyder-Wright, Caroline M. Weight, Pascal F. Durrenberger, Robert S. Heyderman, Stephen B. Gordon, Hermelijn H. Smits, Britta C. Urban, Jamie Rylance, Andrea M. Collins, Mark D. Wilkie, Lepa Lazarova, Samuel C. Leong, Maria Yazdanbakhsh, Daniela M. Ferreira

JOURNAL OF CLINICAL INVESTIGATION (2022)

Article Public, Environmental & Occupational Health

Association between household air pollution and nasopharyngeal pneumococcal carriage in Malawian infants (MSCAPE): a nested, prospective, observational study

Mukesh K. Dherani, Daniel Pope, Terence Tafatatha, Ellen Heinsbroek, Ryan Chartier, Thandie Mwalukomo, Amelia Crampin, Elena Mitsi, Esther L. German, Elissavet Nikolaou, Carla Solorzano, Daniela M. Ferreira, Todd D. Swarthout, Jason Hinds, Kevin Mortimer, Stephen B. Gordon, Neil French, Nigel G. Bruce

Summary: This study aimed to assess the association between exposure to household air pollution and the prevalence and density of S pneumoniae carriage among children. The study found a significant association between household air pollution exposure and the prevalence of nasopharyngeal S pneumoniae carriage, providing empirical evidence for the potential mechanistic association between exposure to household air pollution and childhood pneumonia.

LANCET GLOBAL HEALTH (2022)

No Data Available